Our Team

CO-DIRECTOR AND PRINCIPAL INVESTIGATOR

John Morton is Professor of Nanoelectronics & Nanophotonics at University College London and the Director of the UCL Quantum Science and Technology Institute. His research takes spins of electrons and nuclei in a range of nano-scale materials and devices to develop a new generation of quantum technologies, including quantum sensors, quantum memories, and quantum computers.

CO-DIRECTOR

Mete Atatüre is Professor of Physics at the University of Cambridge and Head of the Cavendish Laboratory. His current research efforts include optical control of spin-photon interfaces in solids, investigations of novel quantum materials and devices, and development of nanoscale quantum sensors for life sciences.

CO-DIRECTOR

Professor Dame Molly Stevens FRS FREng FMedSci is John Black Professor of Bionanoscience at the University of Oxford (Department of Physiology, Anatomy and Genetics and Institute of Biomedical Engineering) and part-time Professor at Imperial College London and the Karolinska Institute.

Professor Stevens’ multidisciplinary research balances the investigation of fundamental science with the development of technologies and designer biomaterials to address some of the major healthcare challenges across diagnostics, advanced therapeutics and regenerative medicine.

SENIOR UK RESEARCH HUB MANAGER

Adam is responsible for the day-to-day strategic and operational delivery of our programme. He manages the Hub’s projects, finances, stakeholder relationships, reporting, risk management, and compliance. Adam works closely with our researchers to accelerate scientific progress and ensure milestones are met on time and within budget. He also drives new funding opportunities and manages the legal and ethical aspects of the Hub’s operations.

Adam’s background is in the life sciences, with a PhD in Interdisciplinary Biomedical Research. He began his journey into applying quantum technologies for healthcare at the Medicines Discovery Catapult, where he developed use cases for quantum computing in the pharmaceutical industry.

SENIOR COMMUNICATIONS MANAGER

Amy is responsible for leading and implementing the Hub’s communications strategy, including developing the Q-BIOMED website, social channels and internal communications. She also leads on all Hub events, including stakeholder workshops, conferences and public outreach events.

Amy has a PhD in Biomedical Sciences and has worked in science communication for the past seven years, with experience in both the higher education and charitable sectors.

CO-INVESTIGATOR

Head of Magnetoencephalography, University College London

CO-INVESTIGATOR

Professor of Physics, Heriot-Watt University

CO-INVESTIGATOR

Associate Professor of Physics and Astronomy, University College London

CO-INVESTIGATOR AND CLINICAL STEERING GROUP

Honorary Consultant Psychiatrist at Queen Square National Hospital for Neurology and Neurosurgery, and Programme Leader at University College London

CO-INVESTIGATOR

Professor of Organic Chemistry and Chemical Biology, University College London

CO-INVESTIGATOR AND CLINICAL STEERING GROUP

Kinross Professor of Neuropsychiatry, University College London and Director of the UCL-Max Planck Centre for Computational Psychiatry and Ageing

CO-INVESTIGATOR AND CLINICAL STEERING GROUP

Research group leader at the Early Cancer Institute, University of Cambridge and Co-Lead of the Cancer Research UK Cambridge Centre Thoracic Cancer Programme

CO-INVESTIGATOR

Professor of BioNano Engineering, University of Cambridge

CO-INVESTIGATOR

Professor of Physics, Heriot-Watt University

CO-INVESTIGATOR

Associate Professor of Physics, University of Warwick

CO-INVESTIGATOR

Lecturer in Science, Technology and Society, University College London

DEPUTY DIRECTOR AND CO-INVESTIGATOR

Lecturer and Royal Society Research Fellow, University of Cambridge

CO-INVESTIGATOR AND CLINICAL STEERING GROUP

Professor of Cardiology, University College London

CO-INVESTIGATOR

Professor of Chemical Sciences, Heriot-Watt University

CO-INVESTIGATOR

Professor of Chemistry, University of Warwick

CO-INVESTIGATOR

Research Fellow in Biochemical Engineering, University College London

CO-INVESTIGATOR AND CLINICAL STEERING GROUP

Professor of Biochemistry, University of Cambridge

CO-INVESTIGATOR

Professor of Physics, University of Warwick

CO-INVESTIGATOR AND CLINICAL STEERING GROUP

Professor of Virology, University College London

CO-INVESTIGATOR

Professor of Experimental Physics, University of Warwick

CO-INVESTIGATOR

Professor of Physics and Director of the Healthcare Biomagnetics Laboratory, University College London

CO-INVESTIGATOR

Professor of Healthcare Engineering, Imaging and Enterprise, University College London

CO-INVESTIGATOR AND CLINICAL STEERING GROUP

Professor of Magnetic Resonance and Cancer Imaging, University College London

CO-INVESTIGATOR

Professor of Physics, University College London

CO-INVESTIGATOR AND CLINICAL STEERING GROUP

Professor of Paediatric and Developmental Pathology, University College London

CO-INVESTIGATOR AND CLINICAL STEERING GROUP

Professor of Global Health, University College London

CO-INVESTIGATOR

Professor of Healthcare Engineering, University College London

CO-INVESTIGATOR

Associate Professor of Chemistry, Heriot-Watt University

DEPUTY DIRECTOR, CO-INVESTIGATOR AND CLINICAL STEERING GROUP

Senior Research Fellow and Honorary Consultant at the National Hospital for Neurology and Neurosurgery, UCLH and the Institute of Neurology, University College London

CO-INVESTIGATOR AND CLINICAL STEERING GROUP

Professor of Neurology, University College London

CO-INVESTIGATOR

Professor of Experimental Physics, Cardiff University